Cutting radiation in CT scans: a new test of Ultra-Low-Dose imaging

NCT ID NCT05840003

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This trial tests whether an ultra-low-dose CT scan, using a new image reconstruction algorithm, can produce images good enough for diagnosing lung, abdominal-pelvic, and bone lesions, compared to a standard-dose CT scan. About 116 adults will receive both scans as part of their usual care. The goal is to see if the ultra-low-dose images are of sufficient quality to be used routinely, potentially reducing radiation exposure without compromising diagnostic accuracy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Ultra-Low-Dose thoraco-abdominopelvic computed tomography (CT) scan using the Precise Image reconstruction algorithm
What this could lead to
If ultra-low-dose CT scans prove as good as standard scans, patients could undergo imaging with far less radiation exposure, reducing long-term risks.
What could go wrong
The trial is relatively small and early, and image quality may not be sufficient for all diagnoses. There is also a risk that the ultra-low-dose scans miss subtle lesions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMEN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU

    Nîmes, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.